ICD-10-CM Billable Code

M1A.0

Idiopathic chronic gout

Clinical Classification Guidelines

Inclusion Terms

  • Chronic gouty bursitis
  • Primary chronic gout

Medical Intelligence & Overview

Idiopathic chronic gout, classified under ICD-10 code M1A.0, is a long-term form of gout characterized by persistent inflammation due to uric acid crystal deposits in joints and surrounding tissues. Unlike acute gout attacks, which occur suddenly and resolve within days, chronic gout involves ongoing symptoms and joint damage. It often progresses from episodic gout if left untreated, leading to joint deformities and reduced mobility. Recognized as primary chronic gout, this condition requires careful management to prevent joint destruction and improve quality of life. It is important for individuals to understand its causes, symptoms, diagnosis, and potential treatment options.

Causes & Symptoms

Clinical Causes: Overproduction of uric acid due to genetic factors or metabolic conditions. Inadequate excretion of uric acid by the kidneys. Diet high in purine-rich foods such as red meat, shellfish, and alcohol. Obesity and certain medications like diuretics that increase uric acid levels. Chronic dehydration or kidney dysfunction impairing uric acid clearance.

Key Symptoms: Persistent joint swelling and tenderness, especially in the toes, ankles, knees, or wrists. Formation of tophi (hard uric acid deposits under the skin). Recurrent episodes of joint inflammation that may become more frequent over time. Limited joint movement and deformities in advanced cases. Chronic discomfort or a persistent dull ache in affected joints. Potential development of bursitis, particularly in the bursae surrounding joints like the elbows.

Diagnostic & Treatment

Diagnosis Path: Diagnosing idiopathic chronic gout typically involves a combination of medical history, physical examination, and laboratory tests. Key diagnostic steps include: - Blood tests to measure serum uric acid levels, although elevated levels may not always be present. - Joint fluid analysis via aspiration to identify characteristic monosodium urate crystals. - Imaging studies such as x-rays or ultrasound to detect joint damage, tophi, or uric acid deposits. - Thorough evaluation to rule out secondary causes related to other diseases or medications. The diagnosis is confirmed when chronic gout features are observed alongside the presence of uric acid crystal deposits, without an apparent secondary cause.

Treatment Protocols: Management of idiopathic chronic gout aims to reduce uric acid levels, prevent flare-ups, and minimize joint damage. Typical approaches include: - Lifestyle modifications such as dietary changes to reduce purine intake, maintaining a healthy weight, and staying well-hydrated. - Medications to lower uric acid levels, like allopurinol or febuxostat. - Anti-inflammatory drugs, including NSAIDs or colchicine, during flare-ups. - Colchicine or corticosteroids for managing persistent inflammation. - Regular monitoring of uric acid and joint health to adjust treatment plans. In some cases, long-term therapy to lower uric acid levels is necessary to prevent progression and complications. Early intervention and adherence to the prescribed regimen are essential for effective management.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M1A.0 a billable ICD-10 code?
Yes, M1A.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M1A.0?
Clinical documentation must specify the nature of Idiopathic chronic gout and any associated comorbidities for accurate reporting.

Cite this Clinical Reference